Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients (Q79777448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Tiziana Di Chiara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Gaspare Parrinello

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Maria Donatelli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Salvatore Corrao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Argano C

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Colomba D

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Avellone G

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Licata G

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

15 February 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

25 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

307-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17301824%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002161

25 December 2019

exact match

0 references

cites work

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Fibrosis and hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Clinical aspects of hypertensive myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Monitoring fibrillar collagen turnover in hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Regulation of cardiac collagen: angiotensin and cross-talk with local growth factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Differential protein expression and subcellular distribution of TGFbeta1, beta2 and beta3 in cardiomyocytes during pressure overload-induced hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

1 reference

7 January 2021

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Reduction in Left Ventricular Messenger RNA for Transforming Growth Factor β 1 Attenuates Left Ventricular Fibrosis and Improves Survival Without Lowering Blood Pressure in the Hypertensive TGR(mRen2)27 Rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Increased serum concentrations of procollagen peptides in essential hypertension. Relation to cardiac alterations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Emerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Novel mechanisms linking angiotensin II and early atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodeling, cardiac function, and survival in rat heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Additive effects of losartan and enalapril on blood pressure and plasma active renin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002161

7 January 2021